Progesterone for the prevention of preterm birth
HAYES, Inc.
Record ID 32008000036
English
Authors' objectives:
Progesterone is administered during pregnancy either vaginally (suppository) or intramuscularly (injection) beginning in the second trimester of pregnancy in asymptomatic women at high risk of spontaneous preterm delivery due to various risk factors, including previous preterm delivery or preterm labor, multiple pregnancy, or short cervix, or orally (capsules) in pregnant women admitted with signs of imminent preterm labor, with the objectives of preventing preterm birth, prolonging gestation, and preventing associated infant mortality and morbidity.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2007
URL for published report:
This report has been updated. The current report can be purchased from: http://www.hayesinc.com/hayes/crd/?crd=6791
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Premature Birth
- Progesterone
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2007 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.